In a filing, Gilead Sciences, Inc. revealed its 10% Owner GILEAD SCIENCES, INC. acquired Company’s shares for reported $0.37 million on Apr 02 ’24. In the deal valued at $0.76 per share,485,250 shares were bought. As a result of this transaction, GILEAD SCIENCES, INC. now holds 7,345,473 shares worth roughly $481.42 million.
Then, Parsey Merdad sold 2,000 shares, generating $145,920 in total proceeds. Upon selling the shares at $72.96, the Chief Medical Officer now owns 96,304 shares.
Before that, Parsey Merdad sold 8,230 shares. Gilead Sciences, Inc. shares valued at $598,624 were divested by the Chief Medical Officer at a price of $72.74 per share. As a result of the transaction, Parsey Merdad now holds 92,706 shares, worth roughly $6.08 million.
Maxim Group reiterated its Gilead Sciences, Inc. [GILD] rating to a Buy in a research note published on May 01, 2024; the price target was $85. A number of analysts have revised their coverage, including HSBC Securities’s analysts, who increased its forecast for the stock in late April from “a Reduce” to “a Hold”. Truist also remained covering GILD and has decreased its forecast on February 22, 2024 with a “Hold” recommendation from previously “Buy” rating. Deutsche Bank started covering the stock on November 09, 2023. It rated GILD as “a Hold”.
Price Performance Review of GILD
On Monday, Gilead Sciences, Inc. [NASDAQ:GILD] saw its stock jump 1.17% to $65.54. Over the last five days, the stock has lost -0.61%. Gilead Sciences, Inc. shares have fallen nearly -19.10% since the year began. Nevertheless, the stocks have fallen -16.53% over the past one year. While a 52-week high of $87.86 was reached on 01/19/24, a 52-week low of $64.33 was recorded on 05/03/24. SMA at 50 days reached $70.39, while 200 days put it at $75.98. A total of 7.07 million shares were traded, compared to the trading of 7.82 million shares in the previous session.
Levels Of Support And Resistance For GILD Stock
The 24-hour chart illustrates a support level at 64.73, which if violated will result in even more drops to 63.93. On the upside, there is a resistance level at 65.95. A further resistance level may holdings at 66.37. The Relative Strength Index (RSI) on the 14-day chart is 35.09, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.78, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 66.11%. Stochastics %K at 21.60% indicates the stock is a holding.
